These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Nephrogenic systemic fibrosis]. Breitschaft A, Stahlmann R. Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227 [Abstract] [Full Text] [Related]
3. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury. Kalb RE, Helm TN, Sperry H, Thakral C, Abraham JL, Kanal E. Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707 [Abstract] [Full Text] [Related]
5. Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders. Cowper SE, Kuo PH, Bucala R. Arthritis Rheum; 2007 Oct; 56(10):3173-5. PubMed ID: 17907160 [No Abstract] [Full Text] [Related]
6. Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency. Chewning RH, Murphy KJ. J Vasc Interv Radiol; 2007 Mar; 18(3):331-3. PubMed ID: 17377176 [Abstract] [Full Text] [Related]
7. Clinical and histological findings in nephrogenic systemic fibrosis. Cowper SE, Rabach M, Girardi M. Eur J Radiol; 2008 May; 66(2):191-9. PubMed ID: 18325705 [Abstract] [Full Text] [Related]
9. Nephrogenic systemic fibrosis: a dermatologist's perspective. Girardi M. J Am Coll Radiol; 2008 Jan; 5(1):40-4. PubMed ID: 18180008 [Abstract] [Full Text] [Related]
10. Nephrogenic systemic fibrosis: a serious iatrogenic disease of renal failure patients. Khurram M, Skov L, Rossen K, Thomsen HS, Marckmann P. Scand J Urol Nephrol; 2007 Jan; 41(6):565-6. PubMed ID: 17934986 [Abstract] [Full Text] [Related]
11. Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease. Shenoy C. Am J Med; 2008 Jan; 121(1):e11; author reply e13. PubMed ID: 18187056 [No Abstract] [Full Text] [Related]
12. Safety update on the possible causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis. Pedersen M. J Magn Reson Imaging; 2007 May; 25(5):881-3. PubMed ID: 17457808 [No Abstract] [Full Text] [Related]
13. [Nephrogenic systemic fibrosis]. Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A. G Ital Nefrol; 2008 May; 25(1):14-20. PubMed ID: 18264914 [Abstract] [Full Text] [Related]
14. Nephrogenic systemic fibrosis: more questions and some answers. Morcos SK, Thomsen HS. Nephron Clin Pract; 2008 May; 110(1):c24-31; discussion c32. PubMed ID: 18688172 [Abstract] [Full Text] [Related]
15. The impact of NSF on the care of patients with kidney disease. Abu-Alfa A. J Am Coll Radiol; 2008 Jan; 5(1):45-52. PubMed ID: 18180009 [Abstract] [Full Text] [Related]